These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

618 related articles for article (PubMed ID: 26606673)

  • 1. The contribution of mass spectrometry-based proteomics to understanding epigenetics.
    Noberini R; Sigismondo G; Bonaldi T
    Epigenomics; 2016 Mar; 8(3):429-45. PubMed ID: 26606673
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Accelerating the Field of Epigenetic Histone Modification Through Mass Spectrometry-Based Approaches.
    Lu C; Coradin M; Porter EG; Garcia BA
    Mol Cell Proteomics; 2021; 20():100006. PubMed ID: 33203747
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Proteomics in chromatin biology and epigenetics: Elucidation of post-translational modifications of histone proteins by mass spectrometry.
    Sidoli S; Cheng L; Jensen ON
    J Proteomics; 2012 Jun; 75(12):3419-33. PubMed ID: 22234360
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Biochemical systems approaches for the analysis of histone modification readout.
    Soldi M; Bremang M; Bonaldi T
    Biochim Biophys Acta; 2014 Aug; 1839(8):657-68. PubMed ID: 24681439
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Mass spectrometry-based characterization of histones in clinical samples: applications, progress, and challenges.
    Noberini R; Robusti G; Bonaldi T
    FEBS J; 2022 Mar; 289(5):1191-1213. PubMed ID: 33415821
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Recent advances in mass spectrometry analysis of histone post-translational modifications: potential clinical impact of the PAT-H-MS approach.
    Bonaldi T; Noberini R
    Expert Rev Proteomics; 2016; 13(3):245-50. PubMed ID: 26822344
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Proteomics contributions to epigenetic drug discovery.
    Noberini R; Bonaldi T
    Proteomics; 2023 Dec; 23(23-24):e2200435. PubMed ID: 37727062
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Progress in epigenetic histone modification analysis by mass spectrometry for clinical investigations.
    Önder Ö; Sidoli S; Carroll M; Garcia BA
    Expert Rev Proteomics; 2015; 12(5):499-517. PubMed ID: 26400466
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Functional proteomics in histone research and epigenetics.
    Trelle MB; Jensen ON
    Expert Rev Proteomics; 2007 Aug; 4(4):491-503. PubMed ID: 17705707
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Engineering chromatin states: chemical and synthetic biology approaches to investigate histone modification function.
    Pick H; Kilic S; Fierz B
    Biochim Biophys Acta; 2014 Aug; 1839(8):644-56. PubMed ID: 24768924
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Recent Achievements in Characterizing the Histone Code and Approaches to Integrating Epigenomics and Systems Biology.
    Janssen KA; Sidoli S; Garcia BA
    Methods Enzymol; 2017; 586():359-378. PubMed ID: 28137571
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Characterization of histone post-translational modifications during virus infection using mass spectrometry-based proteomics.
    Kulej K; Avgousti DC; Weitzman MD; Garcia BA
    Methods; 2015 Nov; 90():8-20. PubMed ID: 26093074
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Reader interactome of epigenetic histone marks in birds.
    Bluhm A; Casas-Vila N; Scheibe M; Butter F
    Proteomics; 2016 Feb; 16(3):427-36. PubMed ID: 26703087
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Characterizing crosstalk in epigenetic signaling to understand disease physiology.
    Lempiäinen JK; Garcia BA
    Biochem J; 2023 Jan; 480(1):57-85. PubMed ID: 36630129
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Challenges ahead for mass spectrometry and proteomics applications in epigenetics.
    Kessler BM
    Epigenomics; 2010 Feb; 2(1):163-7. PubMed ID: 22122752
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The top-down, middle-down, and bottom-up mass spectrometry approaches for characterization of histone variants and their post-translational modifications.
    Moradian A; Kalli A; Sweredoski MJ; Hess S
    Proteomics; 2014 Mar; 14(4-5):489-97. PubMed ID: 24339419
    [TBL] [Abstract][Full Text] [Related]  

  • 17. SILAC-based proteomic analysis to dissect the "histone modification signature" of human breast cancer cells.
    Cuomo A; Moretti S; Minucci S; Bonaldi T
    Amino Acids; 2011 Jul; 41(2):387-99. PubMed ID: 20617350
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Quantification of SAHA-Dependent Changes in Histone Modifications Using Data-Independent Acquisition Mass Spectrometry.
    Krautkramer KA; Reiter L; Denu JM; Dowell JA
    J Proteome Res; 2015 Aug; 14(8):3252-62. PubMed ID: 26120868
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Histone proteomics and the epigenetic regulation of nucleosome mobility.
    Cosgrove MS
    Expert Rev Proteomics; 2007 Aug; 4(4):465-78. PubMed ID: 17705705
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Mass spectrometry-based strategies for characterization of histones and their post-translational modifications.
    Su X; Ren C; Freitas MA
    Expert Rev Proteomics; 2007 Apr; 4(2):211-25. PubMed ID: 17425457
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 31.